Deubiquitinase DUB3 Regulates Cell Cycle Progression via Stabilizing Cyclin A for Proliferation of Non-Small Cell Lung Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deubiquitinase DUB3 Regulates Cell Cycle Progression via Stabilizing Cyclin A for Proliferation of Non-Small Cell Lung Cancer Cells
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 4, Pages 297
Publisher
MDPI AG
Online
2019-04-02
DOI
10.3390/cells8040297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses
- (2018) Tanggang Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ubiquitin–Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (USP17) Gene Family, is a Potential Target for Epithelial–Mesenchymal Transition in High-Grade Serous Ovarian Cancer
- (2018) Nuri Yildirim et al. Reproductive Sciences
- CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition
- (2018) Priya K. Gopalan et al. Oncotarget
- USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial–mesenchymal transition through stabilizing SMAD4
- (2017) Chenyang Song et al. TUMOR BIOLOGY
- CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
- (2017) Tongzheng Liu et al. Nature Communications
- Expression and functional implications of USP17 in glioma
- (2016) Manmiao Hu et al. NEUROSCIENCE LETTERS
- Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells
- (2016) Shengchao Zhang et al. ONCOLOGY RESEARCH
- PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression
- (2015) Xiaohan Qu et al. Journal of Translational Medicine
- The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis
- (2015) Cheryl McFarlane et al. Oncotarget
- Cell Cycle-Dependent Expression of Dub3, Nanog and the p160 Family of Nuclear Receptor Coactivators (NCoAs) in Mouse Embryonic Stem Cells
- (2014) Siem van der Laan et al. PLoS One
- Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
- (2011) XiaoDong Huang et al. MOLECULAR CELL
- Deubiquitinases in cancer: new functions and therapeutic options
- (2011) J M Fraile et al. ONCOGENE
- The Deubiquitinating Enzyme USP17 Is Highly Expressed in Tumor Biopsies, Is Cell Cycle Regulated, and Is Required for G1-S Progression
- (2010) C. McFarlane et al. CANCER RESEARCH
- Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A
- (2010) Yaron Pereg et al. NATURE CELL BIOLOGY
- Degradation of cyclin A is regulated by acetylation
- (2009) F Mateo et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started